Floatz logo

Therapeutic Asset Ratings

12,938 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Mb-Cart2019.1
B-Cell Non-Hodgkin Lymphoma
Miltenyi Biomedicine GmbHP1CC (46)
Medi0618
Chronic Pain Syndrome
AstraZenecaP1CC (46)
MIDAZOLAM
HER2 Mutation
BayerP1CC (46)
MIDAZOLAM
Low Back Pain
Balnear and Rehabilitation Sanatorium TechirghiolP1CC (46)
MIDAZOLAM
Tuberous Sclerosis Complex (TSC)
GRIN Therapeutics, Inc.P1CC (46)
MIRVETUXIMAB
Fallopian Tube Carcinoma
Shattuck Labs, Inc.P1CC (46)
MIRVETUXIMAB
Primary Peritoneal Carcinoma
Shattuck Labs, Inc.P1CC (46)
Mitoxantrone
Myeloid Leukemia
University of Colorado, DenverP1CC (46)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Colon Carcinoma
City of Hope Medical CenterP1CC (46)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Rectal Carcinoma
City of Hope Medical CenterP1CC (46)
MOXIFLOXACIN
Cystic Fibrosis
Vertex Pharmaceuticals IncorporatedP1CC (46)
MOXIFLOXACIN
Thalassemia
Novo Nordisk A/SP1CC (46)
Mtr-601
Cerebral Palsy
Motric BioP1CC (46)
N-Acetyl-L-Cysteine
Beta-Thalassemia Major
Assiut UniversityP1CC (46)
NEPENTHE
Low Back Pain
Uskudar UniversityP1CC (46)
Nivolumab
Advanced Solid Tumors Cancer
AbbVieP1CC (46)
NORMAL HUMAN SERUM ALBUMIN
Cerebral Artery Occlusion
Tianjin Huanhu HospitalP1CC (46)
oa-235i
Metabolic Dysfunction-Associated Steatohepatitis
Oasis Pharmaceuticals, LLCP1CC (46)
Omeprazole
Tuberous Sclerosis Complex (TSC)
GRIN Therapeutics, Inc.P1CC (46)
Omnipaque
Cancer
Alison StopeckP1CC (46)
Oxygen
Sleep Apnea Syndrome
Johns Hopkins UniversityP1CC (46)
Palbociclib
PIK3CA Mutation
Relay Therapeutics, Inc.P1CC (46)
Palbociclib
Unresectable Solid Tumor
Relay Therapeutics, Inc.P1CC (46)
Panobinostat
ER+ Breast Cancer
Boundless Bio, Inc.P1CC (46)
Parsaclisib
T-Cell Non-Hodgkin Lymphoma
Walter HanelP1CC (46)
Showing 701 to 725 of 12,938 assets
PreviousPage 29 of 518Next